Symptomatic ICH and outcomes in patients after IV tPA A business of risk or risky business?

被引：8

作者：

Southerland, Andrew M. ^{[1
]}

Malik, Shaneela ^{[1
]}

Johnston, Karen C. ^{[1
]}

机构：

[1] Univ Virginia Hlth Syst, Dept Neurol, Charlottesville, VA 22908 USA

来源：

NEUROLOGY | 2011年 / 77卷 / 04期

关键词：

STROKE; THROMBOLYSIS; HEMORRHAGE; ALTEPLASE;

D O I：

10.1212/WNL.0b013e3182267bea

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：315 / 316

页数：2

共 10 条

[1] Survey of emergency physicians about recombinant tissue plasminogen activator for acute ischemic stroke [J].

Brown, DL ;

Barsan, WG ;

Lisabeth, LD ;

Gallery, ME ;

Morgenstern, LB .

ANNALS OF EMERGENCY MEDICINE, 2005, 46 (01) :56-60

[2]

Hacke W, 2004, LANCET, V363, P768

[3] Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke [J].

Hacke, Werner ;

Kaste, Markku ;

Bluhmki, Erich ;

Brozman, Miroslav ;

Davalos, Antoni ;

Guidetti, Donata ;

Larrue, Vincent ;

Lees, Kennedy R. ;

Medeghri, Zakaria ;

Machnig, Thomas ;

Schneider, Dietmar ;

von Kummer, Ruediger ;

Wahlgren, Nils ;

Toni, Danilo .

NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (13) :1317-1329

[4] A predictive risk model for outcomes of ischemic stroke [J].

Johnston, KC ;

Connors, AF ;

Wagner, DP ;

Knaus, WA ;

Wang, XQ ;

Haley, EC .

STROKE, 2000, 31 (02) :448-455

[5] Can multivariable risk-benefit profiling be used to select treatment-favorable patients for thrombolysis in stroke in the 3-to 6-hour time window? [J].

Kent, David M. ;

Selker, Harry P. ;

Ruthazer, Robin ;

Bluhmki, Erich ;

Hacke, Werner .

STROKE, 2006, 37 (12) :2963-2969

[6] TISSUE-PLASMINOGEN ACTIVATOR FOR ACUTE ISCHEMIC STROKE [J].

MARLER, JR ;

BROTT, T ;

BRODERICK, J ;

KOTHARI, R ;

ODONOGHUE, M ;

BARSAN, W ;

TOMSICK, T ;

SPILKER, J ;

MILLER, R ;

SAUERBECK, L ;

JARRELL, J ;

KELLY, J ;

PERKINS, T ;

MCDONALD, T ;

RORICK, M ;

HICKEY, C ;

ARMITAGE, J ;

PERRY, C ;

THALINGER, K ;

RHUDE, R ;

SCHILL, J ;

BECKER, PS ;

HEATH, RS ;

ADAMS, D ;

REED, R ;

KLEI, M ;

HUGHES, S ;

ANTHONY, J ;

BAUDENDISTEL, D ;

ZADICOFF, C ;

RYMER, M ;

BETTINGER, I ;

LAUBINGER, P ;

SCHMERLER, M ;

MEIROSE, G ;

LYDEN, P ;

RAPP, K ;

BABCOCK, T ;

DAUM, P ;

PERSONA, D ;

BRODY, M ;

JACKSON, C ;

LEWIS, S ;

LISS, J ;

MAHDAVI, Z ;

ROTHROCK, J ;

TOM, T ;

ZWEIFLER, R ;

DUNFORD, J ;

ZIVIN, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (24) :1581-1587

[7] Hemorrhage after thrombolytic therapy for stroke - The clinically relevant number needed to harm [J].

Saver, Jeffrey L. .

STROKE, 2007, 38 (08) :2279-2283

[8] Number Needed to Treat to Benefit and to Harm for Intravenous Tissue Plasminogen Activator Therapy in the 3-to 4.5-Hour Window [J].

Saver, Jeffrey L. ;

Gornbein, Jeffrey ;

Grotta, James ;

Liebeskind, David ;

Lutsep, Helmi ;

Schwamm, Lee ;

Scott, Phillip ;

Starkman, Sidney .

STROKE, 2009, 40 (07) :2433-2437

[9] Patient outcomes from symptomatic intracerebral hemorrhage after stroke thrombolysis [J].

Strbian, D. ;

Sairanen, T. ;

Meretoja, A. ;

Pitkaniemi, J. ;

Putaala, J. ;

Salonen, O. ;

Silvennoinen, H. ;

Kaste, M. ;

Tatlisumak, T. .

NEUROLOGY, 2011, 77 (04) :341-348

[10] Thrombolysis with alteplase for acute ischaemic stroke in the Safe implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST):: an observational study [J].

Wahlgren, Nils ;

Ahmed, Niaz ;

Davalos, Antoni ;

Ford, Gary A. ;

Grond, Martin ;

Hacke, Werner ;

Hennerici, Michael G. ;

Kaste, Markku ;

Kuelkens, Sonja ;

Larrue, Vincent ;

Lees, Kennedy R. ;

Roine, Risto O. ;

Soinne, Lauri ;

Toni, Danilo ;

Vanhooren, Geert .

LANCET, 2007, 369 (9558) :275-282

← 1 →